These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 21633100

  • 1. Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation.
    Park HW, Kim Y, Kim KH, Rozen S, Najafian B, Mauer M.
    Nephrol Dial Transplant; 2012 Jan; 27(1):107-14. PubMed ID: 21633100
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
    Park HW, Kim Y, Kim KH, Jeong HJ, Shin MH, Rozen S, Mauer M.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):110-7. PubMed ID: 17907098
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 4. AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury.
    Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK.
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1345-53. PubMed ID: 18400868
    [Abstract] [Full Text] [Related]

  • 5. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH, Kim Y, Park HW, Jeong HJ, Mauer M.
    J Nephrol; 2003 Jun; 16(2):196-202. PubMed ID: 12768066
    [Abstract] [Full Text] [Related]

  • 6. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
    Fujihara CK, Malheiros DM, Zatz R.
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
    [Abstract] [Full Text] [Related]

  • 7. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D, Moritz ML, Vats A, Janosky JE.
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [Abstract] [Full Text] [Related]

  • 9. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
    Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin II type-1 receptor blocker losartan on age-related cardiovascular risk in spontaneously hypertensive rats.
    Mihailović-Stanojević N, Miloradović Z, Grujić-Milanović J, Ivanov M, Jovović D.
    Gen Physiol Biophys; 2009 Sep; 28 Spec No():112-8. PubMed ID: 19893088
    [Abstract] [Full Text] [Related]

  • 11. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
    Inserra F, Basso N, Ferder M, Userpater M, Stella I, Paglia N, Inserra P, Tenembaum D, Ferder L.
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):341-6. PubMed ID: 19574289
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A, Hernández-Perera O, Díaz-Herrera P, Ucero ÁC, Anabitarte-Prieto A, Losada-Cabrera A, Ortiz A, Rodríguez-Pérez JC.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 14. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
    Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N.
    Regul Pept; 2005 Dec 15; 132(1-3):59-66. PubMed ID: 16229907
    [Abstract] [Full Text] [Related]

  • 15. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I.
    Am J Physiol Renal Physiol; 2010 Oct 15; 299(4):F758-66. PubMed ID: 20668096
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
    Miloradović Z, Jovović D, Mihailović-Stanojević N, Milanović JG, Milanović S.
    Can J Physiol Pharmacol; 2008 Apr 15; 86(4):210-4. PubMed ID: 18418431
    [Abstract] [Full Text] [Related]

  • 17. [Renal hemodynamics and development of renal fibrotic lesions during hypertension].
    Placier S, Flamant M, Boffa JJ, Dussaule JC, Chatziantoniou C.
    Arch Mal Coeur Vaiss; 2006 Apr 15; 99(7-8):697-700. PubMed ID: 17061447
    [Abstract] [Full Text] [Related]

  • 18. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
    Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B.
    J Pharmacol Exp Ther; 2007 Oct 15; 323(1):85-93. PubMed ID: 17636006
    [Abstract] [Full Text] [Related]

  • 19. Sildenafil treatment prevents glomerular hypertension and hyperfiltration in rats with renal ablation.
    Tapia E, Sanchez-Lozada LG, Soto V, Manrique AM, Ortiz-Vega KM, Santamaría J, Medina-Campos ON, Cristóbal M, Avila-Casado C, Pedraza-Chaverri J, Rodríguez-Iturbe B, Franco M.
    Kidney Blood Press Res; 2012 Oct 15; 35(4):273-80. PubMed ID: 22378379
    [Abstract] [Full Text] [Related]

  • 20. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G, Zatz R.
    Am J Physiol Renal Physiol; 2004 May 15; 286(5):F945-54. PubMed ID: 15075190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.